Inhibition of Lymphocyte Cytotoxicity and Mitogen-induced Transformation of Lymphocytes by Human Skin Homogenates  by McKinney, Churchill et al.
0022-202X/79/7204-0 153$02.00/ 0 
THE JOURNAL OF INV ESTIGATIV E DERMATOLOGY, 72:153-156,1979 
Copyright © 1979 by The Williams & Wilkins Co. 
Vol. 72, No.4 
Printed in U.S.A. 
Inhibition of Lymphocyte Cytotoxicity and Mitogen-induced 
Transformation of Lymphocytes by Human Skin Homogenates 
CHURCHILL McKINNEY PH.D ., ALEXANDER J. RZEPIELA, AND NEAL S. PENNEYS M_D., PH.D. 
Departm.en.ts of Microbiology and Derm.atology, University of Miami School of Medicine, Miam.i, Florida, U. S. A. 
Limitation of the inflammatory cascade has been dem-
onstrated in man by an inhibitor(s) of the prostaglandin 
system and by inhibitor(s) for chemotaxis of leukocytes. 
Other factors may exist in vivo that inhibit other inflam-
matory sequences. In this report, homogenates from hu-
man skin interfered with 2 standard assays of lympho-
cyte function, mitogen-induced transformation and cy-
totoxicity while homogenates of human placenta did not. 
Differential centrifugation studies located inhibitory fac-
tor(s) primarily in the nuclear fractions. Therefore, re-
versible transitory depressions of the cell-mediated im-
mune response that are observed concomitantly with 
chronic dermatoses may reflect release of inhibitory ma-
terial from dermatitic skin in vivo. 
Although the complex mechanisms involved in t he generation 
of inflammatory and immune skin reactions have been exten-
sively studied, the mechanisms of limitation 01' cessation of 
these reactions have received little attention and remain ob-
scure. Until recently, it was generally assumed that inflamma-
tion stopped when the offending antigen or irritant was effec-
tively removed and inflammatory mediators cleared [1,2]. How-
ever , limitation of the inflammatory reaction by soluble factors 
is equa lly pla usible and has been demonstrated in man for the 
prostaglandin system by the detection of endogenous inhibi-
tor(s) of prostaglandin biosynthesis released during destructive 
inflammatory and immunologic reactions in skin [3-6] and for 
the chemotactic system by the isolation of chemotactic factor 
inactivator from human serum [7]. 
The existence of t hese endogenous inhibitors of diverse as-
pects of t he inflammatory sequence suggested to us that other 
factors exis t in vivo that limit other aspects of the cutaneous 
inflammatory-immune response. We chose to investigate the 
effects of skin homogenates prepared from normal human skin 
on a lymphocyte-mediated cytotoxic reaction , since cell disrup-
tion is a feature of many immune reactions in skin, and on the 
transformation of human lymphocytes by various mitogens, 
since ma ny cellula]' immune reactions in skin may be in part 
mediated by these cells. 
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Abbreviations: 
ADCC: antibody-dependent cell-med iated cytotoxicity 
Con A: concanavalin A 
CRBC: Chicken erythrocytes 
LSM: Lymphocyte Sepa ration Medium 
PH A: phytohemagglu t inin 
PWM: pokeweed mitogen 
SIg: surface immunoglobu lin 
METHODS 
With informed consent, skin punch biopsies (4 mm across) were 
obtained from norma l voluntee rs afte r inj ection of I % xylocaine or from 
a mpu tated limbs with a Davol dermatome. Skin samples were sterilized 
by exposure to 70% ethanol for 5 min prior to removal and stored intact 
at -20°C un t il use. Skin specimens were then thawed a nd placed in 5x 
ant ibiotics (Penicillin 500 IU/ ml , Fungizone 1.25 J.Lg/ml and Strepto-
mycin 500 J.Lg/ ml) for 1 hr. Human placentas were obtained at de livery, 
frozen immediate ly in liquid nitrogen and stored at -20°C un ti l use. 
For direct assay, skin and placental specimens were minced with 
surgical scissors a nd then homogenized in a Polytron in medium RPMI-
1640 or 0.85% NaCI at 4°C. Differential cent ri fugation experiments 
were performed on the skin and placental homogenates according to 
the fo llowing method of Widnell a nd Tata [8]: Homogenates were 
resuspended in .0 1 M Tris-HCI buffer, pH 8.5, supplemented with 3 mM 
MgCI" a nd fil te red through cheese cloth to remove fragments of dermis. 
The fil t rate was then layered a bove 0.32 M sucrose in the buffer solu tion 
and cent rifuged fo r 10 min at 700 xR. T he supernatant, containing 
other organelles, was removed a nd saved fo r further assay. T he pellet, 
referred to as the crude nuclear fraction, was resuspended in 2.4 M 
sucrose supplemented with 1.0 M MgCb in Tris-HCI, pH 8.5, a nd spun 
for 2 hr at 50,000 xg in a Beckman Model L3-50 ultracentri fuge. The 
50,000 xg pellet, conta ining whole nuclei, was saved for further assay. 
The 50,000 xg supernatant was later assayed and shown to contain 
most of the inhibi tory activity. Throughout this paper it will be referred 
to as the nuclear fraction. Finally a soluble fraction was obtained by 
spinning the 700 xg supernatant at 105,000 xg for 10 min. The pellet 
from this spin represented the other organelles less nuclei. Protein 
determinations were performed on the nuclear fraction according to 
Lowry et a l [9]. 
To determine the inhibi to ry effects of epidermal subcellular fractions 
in cellular immune assays in vitro 2 cytotoxic assays, phytohemagglu-
tinin (PHA)-induced lymphocyte cytotoxicity and ant ibody-dependent 
cell -mediated cytotoxic ity (ADCC), were employed according to the 
methods of Perlmann et a l with slight modifications [10,11]' Human 
mononuclear ce ll were purified from whole blood with Lymphocyte 
Separ ation Medium (LSM, Litton Bionetics) after collection in pre-
servative free hepa.rin (100 IU / ml). Cul tures contained 1.25 x 10" 
lymphocytes in 0.25 ml, 0.5 x 10" Na/ ,ICrO.,-labeled chicken erythro-
cyt.es (Crbc) in 0.25 ml, plus 25 {Ig PHA or 10- ' - 10- 1; dilution of ra bbit 
a nti-Crbc ant ibody in 10 {d . Control cul tures contained 5 x 10" unlabeled 
Crbc in place of lymphocytes. All cul tures were main ta ined in medium 
HPMI-1640 with heat inactivated 10% fetal bovine serum a nd I x 
antibiotics. 25 J.LI a liquots of each skin fraction were then added to the 
reaction mix tures and the cul tures were a llowed to incubate for 18 hr 
at 37°C. The cultures were then cent rifuged at 400 xg and the amount 
of radioactivit.y in the supernatant and in the pellet determined by 
gamma spectrometry. Results a re calculated a nd expressed as follows: 
153 
[
coun ts per min (CPM) supernatant] , 
x 100 = % release .,ICr· 
CPM supernatant + CPM pellet ' 
% release experimental - % release cont rol = % cytotoxicity; 
100 X 1 - . = % inhibit ion. [ [ 
% cytotoxicity + skin fraction ] ] 
% cytotoxicity without skin fraction 
Data are expressed as the average of at least 3 replicates ± 1 standard 
deviation. 
For determination of the effects of skin homogenates on the blasto-
genic response of huma n leukocytes to 3 different mitogens, lympho-
cytes were obtained as described above. Lymphocyte responses to 
mitogens were assayed in 96 well, Oat.-bottomed microplates (Flow 
Laboratory). Lymphocytes, 10" cells in 0.2 ml medium, were added to 
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individual wells wh ich then received either PHA, l.0 fl.g , concanavalin 
A, 1.0 fl.g, or pokeweed mitogen, 5.0 fl.g, in 10 fl.l. Control cultures 
contained 10 fl.1 complete medium (RPMI-1640 anel 10% heat inacti-
vated fetal bovine serum and antibiotics) while test cultures contained 
10 fl.l skin homogenate in medium, a volume which gives the same final 
dilu tion of test homogenate as that examined in the cytotoxic assays. 
Each determination was performed with 6 replicates. Cu ltures were 
incubated fo r 3 days with mitogens in a humidified atmosphere con-
taining 5% COt in air at 37°C. DNA synthesis was measured by the 
incorporation of ["H]thymidine introduced into cul tures 18 hr prior to 
termination. Cu ltu res were terminated by use of the Skat Ton (Flow 
Laboratories) which collected nucleic acid on glass fiber filters. The 
filters were dried and radioactivity determined in a toluene-based 
scintillant. Flow cytometry was performed according to the method of 
Krishan [12] using a TPS- l Cell Sorter (Coulter Electronics, Hialeah, 
Fla.). Cells bearing SIg were visualized according to a method.. of 
Rabell ino et al [13]. 
Lymphotoxin, reported to be a solu ble nondialyzable lymphokine 
released by activated lymphocytes, was assayed for by the method of 
Knudsen, Ahmed, and Sell [14]. 
RESULTS 
The add it ion of crude skin homogenates to the mitogen-
induced cytotoxic reaction described by Perlmann and Perl-
mann [10] resulted in significant inhibi t ion of eryt hrocyte lysis. 
A mean of 50% inhibition of the mitogen-stimulated lysis of 
chicken erythrocytes was demonstrated in 10 experiments using 
9 different preparations of skin homogenate from 9 different 
sources. The mean percent lysis of control cult ures was 35.7 ± 
10.2 and for homogenate-treated cultures, 17.0 ± 8.4 (p < .001 
when compared to untreated control) . S imilar preparations 
from placental tissue failed to affect the cytotoxic reaction. 
D ifferential centrifugation located most of the inhibitory 
material in the crude nuclear fraction, little being detected in 
other organelle fractions and in the 105,000 xg supernatant 
(Fig 1). M ore elaborate nuclear purification suggested that t he 
inhibitory material was not whole nuclei, since it was retained 
in the supernatant above a 2.4 M sucrose cushion . However, the 
material is sedimentable at 105,000 xg, confirm·ing the partic-
ulate nature of the factor(s). Extraction of homogenate with 
chloroform-methanol (2:1) and subsequent testing of the solu-
bilized organic and aqueous phase extracts indicated that the 
fa ctor(s) remained in the aqueous phase and was not a lipid . 
This factor is therefore distinct from the lipid factor(s) that 
interferes with the biosynthesis of prostaglandin. Further char-
acterization of the material indicated that the majority of the 
activ ity was destroyed by heat (lOO°C, 5 min) sonication (l0 
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FIG 1. Effects of epidermal subcellular fractions on the inhibition of 
PHA-induced lymphocyte cytotoxicity. In this fi gure. the suppression 
of cytotoxicity by skin fractions is expressed as mean percent inhibi tion 
of cytotoxicity observed in the absence of added material. Vertica.l ba.rs 
denote 1 standard deviation. 
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second pulses, 2 min total) and 0.25 N HCI extraction [15]. The 
factor did not pass through a 0.45 Il Millipore filter nor was It 
dialyza ble. These proper t ies imply that this substance(s ) may 
be a structural port ion of the nuclear membrane component. 
Dose-response data showed this substance to be active at a 
concentration as low as 10 Ilg of protein/ml (Fig 2). We therefore 
conclude that an intracellular compound located in the nuclear 
fraction from normal skin can interfere with one of the sta ndard 
in vitro assays of lymphocyte function. 
Whole skin a nd/or various skin fractions are known to bind 
numerous biochemical substances nonspecifically. To eliminate 
t he possibility that our epidermal preparations were binding 
PHA, thus removing it from contact with the leukocytes, cells 
were exposed to PHA for 1 hr a t 37°C prior to the addition of 
homogenate. It is known that PHA binds irreversibly after 30 
min [16]. Under these conditions, PHA-induced cultures pro-
duced 36.7 ± 7.6 mean percent lysis and cultures containing 
both PHA and skin homogenate, 23.9 ± 3.7, a percent inhibition 
of 34 .5 ± 3.8. With no pre-incubation the percent cytotoxicity 
in the presence of PHA alone was 41.1 ± 6.0, of PHA a nd skin 
homogenate, 23.4 ± 2.7; the percent inhibition in the presence 
of skin homogenate was therefore 42.9 ± 9.5. These data suggest 
that the inhibitory activity was not a result of adsorbing PHA 
and removing it from the reaction mixture and that skin ho-
mogenates did not interfere with the binding of PHA to recep-
to rs on the surface of the leukocytes. 
Other assay systems are used to define cellular immune 
phenomena in vitro. One of t hese is the mitogen-induced blast 
transformation of human lymphocytes. We evaluated the ef-
fects of ep iderma l homogenates on .the blastogenic response 
induced by 2 T lymphocyte mitogens, PHA and concanavalin 
A, and 1 mitogen that requires T-B cell cooperation, pokeweed 
mitogen [17]. 
Fig 3 presents matched data, pairing control cult ures with 
cultures containing 10 III of skin homogenate (maintaining the 
same concentration used in cytotoxic experiments). In all ex-
periments and with 3 different mitogens, inhibition of transfor-
mation was observed when skin homogenate was present. 
Throughout these experiments, viability staining with trypan 
blue showed that the cells in contact with nuclear preparations 
for as long as 72 hr (blastogenesis) remained equa lly viable 
when compared to those in control cultures. The epidermal 
fractions were therefore not toxic to leukocytes. In order to 
confirm that this nuclear material was inhibiting cell division 
and not simply interfering with CH]thymidine incorporation, 
. we used flow cytometry to measure the quantity of DNA in 
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FIG 2. Dose-response curve of inhibi tion of PHA-induced cytotox-
icity by nucl ear fraction. 
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stimulated cultures. Using this technology, it was shown that 
stimulated cultures conta ining nuclear fraction did not contain 
cells in G2 phase of the cell cycle, i. e., did not contain dividing 
cells with a 4n complement of D NA (Fig 4). Stimulated control 
cultures, without nuclear materia ls, were shown to contain cells 
in all stages of the cell cycle with a peak representative of G2 
being quite prominent. T herefore, the flow cytometry data 
confirmed that obtained using CH]thymidine: T he mitogen-
induced blast transformation of lymphocytes was inhibited by 
material from the nuclear fraction of normal human epidermis. 
In contrast, t he nuclear fraction material had no effect on 
several assays: T he fluorescent staining of surface Ig, a B cell 
marker, was unchanged. Therefore, the inhibi t ive substance did 
not seem to be nonspecifically altering cell membranes. Fur-
t h ermore, it had no effect on the ADCC reaction, which appears 
to be mediated by Fc receptor bearing cells. T hus, the nuclear 
material was not protecting the target cells from lysis. Further-
more, t hese data confirmed the lack of toxicity of the skin 
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FIG 3. Effects of skin homogenates on the blastogenic response of 
human leukocytes to 3 different mitogens. 
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FIG 4. Histograms of lymphocytes cul tured fo r 72 hr: ( A) medium 
control showing cells only in the GOI and G" nondividing, phases of t he 
cell cycle; (B) PHA-stimulated culture showing a G" and M peak 
representative of DNA replication a nd cell division; (C) medium control 
containing nuclear fraction showing cells only in the GOI a nd G, phases 
of the cell cycle; (D) PHA-stimu lated culture containing nuclear frac· 
tion iLl ustrating cells in GOI and G, but lacking the expected G" and M 
peak indicating that nuclear fraction inhibi ts DNA synthesis a nd cell 
division. P eripheral blood lymphocytes (PBL). 
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fraction. Lastly, the epidermal material had no effect on the 
action of a lymphokine, lymphotoxin. Thus, the mechanism of 
action of this nuclear inhibitor(s) may be directed at the T 
lymphocyte population. 
DISCUSSION 
Patients with chronic dermatoses associated with epidermal 
damage may have depressed cell-mediated immunity. Lobitz, 
Honeyman, and Winkler [18] reported 2 lifelong atopic patients 
who had delayed-type skin test unresponsiveness, inability to 
be sensitized to DNCB, and diminished responsiveness of cul-
tured lymphocytes to PHA; in 1 patient these tests improved 
when remission occurred. Jones, Lewis, and McMarlin [19] 
noted that only 15% of atopic subjects had allergic contact 
sensitivity to Rhus antigen while sensitivity was found in 60% 
of healthy nona topic controls. Furthermore, the survey patch 
test had sensitized 31 % of nonsensitive control group but only 
6% of nonsensit ive atopics. Uehara [20] observed that transient 
suppression of al.ready established tuberculin reactivity oc-
curred when atopic individuals had active dermatitis and nor-
mal reactivity when the rash healed. Marks, Thor, and Lowe 
reported that 4 patients with stable Darier's disease had sup-
pressed in vitro tests of cell-mediated immunity [21]. In a 
guinea pig model, Uehara and Ofuji [15] demonstrated that 
established tuberculin reactivity was transiently suppressed by 
active prelimary irritant and allergic contact dermatitis; normal 
reactivity returned when the dermatitis resolved. Therefore, 
transient suppression of cell-mediated immune reactions seems 
to be related to epidermal damage in general and not necessarily 
to specific immune reactions or the atopic state in skin. 
In t his report, we have shown that material present in human 
skin homogenate and in the nuclear fraction prepared from 
epidermal cells interferes with 2 standard tests of lymphocyte 
function in vitro, PHA-induced cytotoxicity and mitogen-in-
duced blastogenesis. We have also presented evidence t hat 
material in the nuclear frac tion does not interfere with the 
binding of PHA to t he lymphocyte membrane. Fw-thermore, 
the inability of the nuclear frac tion to inhibit ADCC suggests 
that it does not affect Fc receptor-bearing lymphocytes. Due to 
the lack of an inhibitory effect in ADCC it is apparent t hat th e 
substance is not protecting the chicken erythrocyte target cell, 
the same target cell used in the PHA-cytotoxicity assay. Failure 
to diminish SIg staining indicated that this material did not 
bind nonspecifically to the cell membranes. In addition, mate-
rial in t he nuclear fraction did not inhibit the activity of one 
lymphokine, lymphotoxin. Therefore, we postulate that a sub-
stance(s) in the nuclear fraction of normal human epidermis 
interferes specifically with certain T lymph ocyte functions. This 
substance, when chemically released in vivo from dermatitic 
skin, would alter T lymphocyte function and resul t in depressed 
cell-mediated immunity. 
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Announcement 
This announcement replaces one that appeared in February 1979, pg 66, and represents the final program. 
The Third Joint Meeting of the Society for Investigative Dermatology and the European Society for 
Dermatological Research will be held at the RAI Congrescentrum, Amsterdam, The Netherlands, June 
10-14, 1979. Registration will begin at 2:00 PM June 10. 
In addition to formal and poster presentations of current research, special lectures will be given by Dr. 
A. L. de Weck on "Current Problems in Drug Allergy," Dr. Howard Green on "The Cultured Epidermal 
Cell: Molecular Biology and Practical Possibilities," Dr. Aal'on B. Lerner on "Melanomas: Notes on 
Clinical and Laboratory Research," and Dr. Jan G. Waldenstrom on "Paraneoplastic Signals on the Skin." 
Six workshops will be held each of the four days of the meeting and will include such topics as 
Langerhans Cells, Plastic Section Microscopy, Collagen, Mechanism of Hormone Action, DNA Repair, 
Acne, Cellular Mediators of Inflammation, Immune Complex Diseases, Dermal-Epidermal Junction, 
Phaeomelanin, Envu'onmental Carcinogenesis, Cell Culture-Controls of Growth and Differentiation, 
Histocompatibility Antigens in Skin Disease, Biological Basis of Hypopigmentary Skin Disease, Photo-
biology, Oncogenic Viruses, Cutaneous Aging, Keratin, Chemical Mediators of Inflammation, Immunology 
and Immunotherapy of Melanoma, Graft Versus Host Reaction, Biological Effects of PUV A, Wound 
Repair, and Retinoids. 
Those persons who wish to present their work at one of the workshops should write to the Secretary-
Treasurer W. Mitchell Sams, Jr., M.D. at the Department of Dermatology, North Carolina Memorial 
Hospital, Chapel Hill, North Carolina, 27514. 
Members of both Societies will obtain further information and a program in early April 1979. 
Nonmembers wishing to attend should contact Dr. Sams for information regarding housing and other 
arrangements. 
